CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

Molecular Medicine

Volumn 16, Issue 3-4, 2010, Pages 87-91

  Deaglio, Silvia ^a   Aydin, Semra ^a   Grand, Maurizia Mello ^b   Vaisitti, Tiziana ^a   Bergui, Luciana ^a   D'Arena, Giovanni ^c   Chiorino, Giovanna ^b   Malavasi, Fabio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Laboratory of Cancer Genomics   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD38 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANIMAL BEHAVIOR; ANIMAL CELL; ARTICLE; CANCER DIAGNOSIS; CELL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AGED; ANIMALS; ANTIGENS, CD31; ANTIGENS, CD38; CELL GROWTH PROCESSES; CELL LINE; CELL MOVEMENT; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICE; MIDDLE AGED; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 77649154795     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00146     Document Type: Article

References (20)

1. Malavasi F, et al. (2008) Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88:841-86.
2. Deaglio S, et al. (2000) CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem. Immunol. 75:99-120.
3. Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840-7.
4. Crespo M, et al. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 348:1764-75.
5. Matrai Z. (2005) CD38 as a prognostic marker in CLL. Hematology. 10:39-46.
6. Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. (2006) In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood. 108:1135-44.
7. Jaksic O, et al. (2004) CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Blood. 103:1968-9.
8. Damle RN, et al. (2007) CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood. 110:3352-9.
9. Pepper C, et al. (2007) Highly purified CD38(+) and CD38(-) sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia. 21:687-96.
10. Deaglio S, et al. (2003) CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood. 102:2146-2155.
11. Deaglio S, et al. (2007) CD38/CD19: a lipid raft dependent signaling complex in human B cells. Blood. 109:5390-8.
12. Deaglio S, et al. (2005) CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood. 105:3042-50.
13. Patten PE, et al. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 111:5173-81.
14. Tonino SH, Spijker R, Luijks DM, van Oers MH, Kater AP. (2008) No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia. Blood. 112:840-3.
15. Deaglio S, et al. (2007) CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood. 110:4012-21.
16. Deaglio S, et al. (1998) Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160:395-402.
17. Tomfohr J, Lu J, Kepler TB. (2005) Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics. 6:225.
18. Lin TT, et al. (2008) Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient. Br J Haematol 142:595-605.
19. Letilovic T, Vrhovac R, Verstovsek S, Jaksic B, Ferrajoli A. (2006) Role of angiogenesis in chronic lymphocytic leukemia. Cancer 107:925-34.
20. Shanafelt TD, Kay NE. (2006) The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin. Oncol. 33:174-85.